Status unknown
Clinical Efficacy Observation of Fuzheng Jiangzhuo Formula in the Treatment of Heart Failure Complicated by Gastrointestinal Dysfunction
Randomized Controlled Clinical Study on Fuzheng Jiangzhuo Decoction for the Treatment of Heart Failure Complicated with Gastrointestinal Dysfunction
- Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Enrollment
- 30 planned
- Conditions
- Heart Failure Complicated by Gastrointestinal Dysfunction; BD1Z
- Interventions
- Routine Western medicine treatment group; Routine Western medicine treatment plus Fuzheng Jiangzhuo Formula
- Ages
- adults, older adults
- Registry
- ITMCTR2026002503
Full record on ITMCTRSource: WHO ICTRP, processed October 5, 2026
Primary outcomes
- New York Heart Association functional classification (NYHA class)
- N-terminal pro-B-type natriuretic peptide level (NT-proBNP)
- Left Ventricular Ejection Fraction (LVEF), Left Ventricular End-Diastolic Dimension (LVEDD), Left Ventricular End-Systolic Dimension (LVESD), Interventricular Septal Thickness at end-diastole (IVSd), Stroke Volume (SV);
History
Last registry update
Registered
Started